FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W770203779> ?p ?o ?g. }

• W770203779 endingPage "2168" @default.
• W770203779 startingPage "2159" @default.
• W770203779 abstract "ObjectiveTo review the available evidence on the effectiveness of prophylactic topical nonsteroidal anti-inflammatory drugs (NSAIDs) in preventing vision loss resulting from cystoid macular edema (CME) after cataract surgery.MethodsLiterature searches of the PubMed and the Cochrane Library databases were last conducted on January 21, 2015, with no date restrictions. The searches retrieved 149 unique citations. The first author reviewed the abstracts of these articles and selected 27 articles of possible clinical relevance for full-text review. Of these 27 articles, 12 were deemed relevant to analyze in full. Two additional articles were identified from the reference list of the selected articles, and another article was identified from a national meeting. The panel methodologist assigned ratings of level of evidence to each of the selected citations.ResultsNonsteroidal anti-inflammatory drug therapy was effective in reducing CME detected by angiography or optical coherence tomography (OCT) and may increase the speed of visual recovery after surgery when compared directly with placebo or topical corticosteroid formulations with limited intraocular penetration. However, the use of NSAIDs did not alter long-term (≥3 months) visual outcomes. Furthermore, there was no evidence that the benefits observed with NSAID therapy could not be obtained similarly with equivalent dosing of a corticosteroid. The reported impression that there is a pharmacologic drug synergy from the use of both an NSAID and a corticosteroid is not supported by the literature. There is no uniform method of reporting CME in the literature, which prevents accurate assessment of its incidence and response to anti-inflammatory therapies.ConclusionsCystoid macular edema after cataract surgery has a tendency to resolve spontaneously. There is a lack of level I evidence that supports the long-term benefit of NSAID therapy to prevent vision loss from CME at 3 months or more after cataract surgery. Although dosing of NSAIDs before surgery may hasten the speed of visual recovery in the first several weeks after cataract surgery, there is no evidence that this practice affects long-term visual outcomes. Standardized reporting of CME based on OCT may allow for more uniform quantitation of its incidence and more reliable assessment of treatment outcomes. To review the available evidence on the effectiveness of prophylactic topical nonsteroidal anti-inflammatory drugs (NSAIDs) in preventing vision loss resulting from cystoid macular edema (CME) after cataract surgery. Literature searches of the PubMed and the Cochrane Library databases were last conducted on January 21, 2015, with no date restrictions. The searches retrieved 149 unique citations. The first author reviewed the abstracts of these articles and selected 27 articles of possible clinical relevance for full-text review. Of these 27 articles, 12 were deemed relevant to analyze in full. Two additional articles were identified from the reference list of the selected articles, and another article was identified from a national meeting. The panel methodologist assigned ratings of level of evidence to each of the selected citations. Nonsteroidal anti-inflammatory drug therapy was effective in reducing CME detected by angiography or optical coherence tomography (OCT) and may increase the speed of visual recovery after surgery when compared directly with placebo or topical corticosteroid formulations with limited intraocular penetration. However, the use of NSAIDs did not alter long-term (≥3 months) visual outcomes. Furthermore, there was no evidence that the benefits observed with NSAID therapy could not be obtained similarly with equivalent dosing of a corticosteroid. The reported impression that there is a pharmacologic drug synergy from the use of both an NSAID and a corticosteroid is not supported by the literature. There is no uniform method of reporting CME in the literature, which prevents accurate assessment of its incidence and response to anti-inflammatory therapies. Cystoid macular edema after cataract surgery has a tendency to resolve spontaneously. There is a lack of level I evidence that supports the long-term benefit of NSAID therapy to prevent vision loss from CME at 3 months or more after cataract surgery. Although dosing of NSAIDs before surgery may hasten the speed of visual recovery in the first several weeks after cataract surgery, there is no evidence that this practice affects long-term visual outcomes. Standardized reporting of CME based on OCT may allow for more uniform quantitation of its incidence and more reliable assessment of treatment outcomes." @default.
• W770203779 created "2016-06-24" @default.
• W770203779 creator A5006761392 @default.
• W770203779 creator A5039903952 @default.
• W770203779 creator A5062196360 @default.
• W770203779 creator A5063934250 @default.
• W770203779 creator A5073166135 @default.
• W770203779 creator A5073193063 @default.
• W770203779 date "2015-11-01" @default.
• W770203779 modified "2023-10-18" @default.
• W770203779 title "Topical Nonsteroidal Anti-inflammatory Drugs and Cataract Surgery" @default.
• W770203779 cites W1889427285 @default.
• W770203779 cites W1965353306 @default.
• W770203779 cites W1969204378 @default.
• W770203779 cites W1979467136 @default.
• W770203779 cites W1984685317 @default.
• W770203779 cites W1985921160 @default.
• W770203779 cites W1989933775 @default.
• W770203779 cites W1989999031 @default.
• W770203779 cites W1994947924 @default.
• W770203779 cites W1996971253 @default.
• W770203779 cites W1998788854 @default.
• W770203779 cites W2007870816 @default.
• W770203779 cites W2007962765 @default.
• W770203779 cites W2010734352 @default.
• W770203779 cites W2013035281 @default.
• W770203779 cites W2021658589 @default.
• W770203779 cites W2026043397 @default.
• W770203779 cites W2026165201 @default.
• W770203779 cites W2031691405 @default.
• W770203779 cites W2032592184 @default.
• W770203779 cites W2037686055 @default.
• W770203779 cites W2039342521 @default.
• W770203779 cites W2039957409 @default.
• W770203779 cites W2044240264 @default.
• W770203779 cites W2057053307 @default.
• W770203779 cites W2060782091 @default.
• W770203779 cites W2067545816 @default.
• W770203779 cites W2082978428 @default.
• W770203779 cites W2087085021 @default.
• W770203779 cites W2105159579 @default.
• W770203779 cites W2111140419 @default.
• W770203779 cites W2139520424 @default.
• W770203779 cites W2160514494 @default.
• W770203779 cites W2165781249 @default.
• W770203779 cites W2192400013 @default.
• W770203779 cites W7322411 @default.
• W770203779 cites W95972928 @default.
• W770203779 doi "https://doi.org/10.1016/j.ophtha.2015.05.014" @default.
• W770203779 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26123091" @default.
• W770203779 hasPublicationYear "2015" @default.
• W770203779 type Work @default.
• W770203779 sameAs 770203779 @default.
• W770203779 citedByCount "115" @default.
• W770203779 countsByYear W7702037792015 @default.
• W770203779 countsByYear W7702037792016 @default.
• W770203779 countsByYear W7702037792017 @default.
• W770203779 countsByYear W7702037792018 @default.
• W770203779 countsByYear W7702037792019 @default.
• W770203779 countsByYear W7702037792020 @default.
• W770203779 countsByYear W7702037792021 @default.
• W770203779 countsByYear W7702037792022 @default.
• W770203779 countsByYear W7702037792023 @default.
• W770203779 crossrefType "journal-article" @default.
• W770203779 hasAuthorship W770203779A5006761392 @default.
• W770203779 hasAuthorship W770203779A5039903952 @default.
• W770203779 hasAuthorship W770203779A5062196360 @default.
• W770203779 hasAuthorship W770203779A5063934250 @default.
• W770203779 hasAuthorship W770203779A5073166135 @default.
• W770203779 hasAuthorship W770203779A5073193063 @default.
• W770203779 hasBestOaLocation W7702037791 @default.
• W770203779 hasConcept C118487528 @default.
• W770203779 hasConcept C126322002 @default.
• W770203779 hasConcept C141071460 @default.
• W770203779 hasConcept C142724271 @default.
• W770203779 hasConcept C16005928 @default.
• W770203779 hasConcept C168563851 @default.
• W770203779 hasConcept C17744445 @default.
• W770203779 hasConcept C199539241 @default.
• W770203779 hasConcept C204787440 @default.
• W770203779 hasConcept C27081682 @default.
• W770203779 hasConcept C2776478404 @default.
• W770203779 hasConcept C2776694085 @default.
• W770203779 hasConcept C2777802072 @default.
• W770203779 hasConcept C2778257484 @default.
• W770203779 hasConcept C2778484676 @default.
• W770203779 hasConcept C2778749236 @default.
• W770203779 hasConcept C2779473830 @default.
• W770203779 hasConcept C2780035454 @default.
• W770203779 hasConcept C2780347916 @default.
• W770203779 hasConcept C31174226 @default.
• W770203779 hasConcept C71924100 @default.
• W770203779 hasConcept C98274493 @default.
• W770203779 hasConceptScore W770203779C118487528 @default.
• W770203779 hasConceptScore W770203779C126322002 @default.
• W770203779 hasConceptScore W770203779C141071460 @default.
• W770203779 hasConceptScore W770203779C142724271 @default.
• W770203779 hasConceptScore W770203779C16005928 @default.

• next